Roles of real-world evidence in severe asthma treatment: challenges and opportunities
Article in ERJ Open Research (December 2022)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Predictive biomarkers for response to omalizumab in patients with severe allergic asthma: a meta-analysis
Article in Expert Review of Respiratory Medicine (June 2022)
Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma
Article in Journal of Personalized Medicine (January 2022)